| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |